BBOT
BridgeBio Oncology Therapeutics, Inc.
NASDAQ: BBOT · HEALTHCARE · BIOTECHNOLOGY
$8.41
+4.34% today
Updated 2026-04-30
Market cap
$702.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$8 – $15
Volume
0.3M
BridgeBio Oncology Therapeutics, Inc. (BBOT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-86.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-706.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+5.8%
2026-03-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.49 | +26.5% | $8.72 | $9.23 | +5.8% |
| 2025-11-12 | $-1.03 | -202.9% | $12.75 | $12.38 | -2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.66 | $-0.49 | +26.5% | — | — |
| 2025-09-30 | $-0.34 | $-1.03 | -202.9% | — | — |
| 2025-06-30 | — | $-50.33 | — | — | — |
| 2025-03-31 | — | $-50.13 | — | — | — |
| 2024-12-31 | — | $0.08 | — | — | — |
| 2024-09-30 | — | $0.10 | — | — | — |
| 2024-06-30 | — | $0.09 | — | — | — |
| 2024-03-31 | — | $0.05 | — | — | — |
Frequently asked questions
Has BridgeBio Oncology Therapeutics, Inc. beaten earnings estimates?
BridgeBio Oncology Therapeutics, Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -86.7% over the last 2 quarters.
How does BBOT stock react to earnings?
BBOT stock has moved an average of +1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.